Search for: "TEVA USA, INC."
Results 181 - 200
of 646
Sort by Relevance
|
Sort by Date
7 Mar 2018, 11:52 am
Teva Pharmaceuticals USA, Inc. [read post]
8 Feb 2018, 7:31 am
Teva Pharmaceuticals USA, Inc., February 5, 2018, Stengel, L.). [read post]
2 Feb 2018, 1:31 pm
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Case 2016-1284, 2016-1787 (Fed. [read post]
23 Jan 2018, 7:29 pm
USA, Inc., 518 F.3d 1353, 1360 (Fed. [read post]
11 Dec 2017, 5:16 pm
The petition of the day is: Teva Pharmaceuticals USA, Inc. v. [read post]
20 Nov 2017, 9:59 am
USA, Inc. v. [read post]
14 Nov 2017, 3:04 pm
USA, Inc.,731 F.3d 1271 (Fed. [read post]
10 Nov 2017, 9:21 am
USA, Inc. v. [read post]
25 Oct 2017, 6:55 am
Other petitioners joined in the case are Apotex, Inc, Teva Pharmaceuticals USA, Fresenius Kabi USA, and Wockhardt Bio AG. [read post]
19 Oct 2017, 2:17 pm
TEVA Pharmaceuticals USA, INC. [read post]
19 Oct 2017, 2:17 pm
TEVA Pharmaceuticals USA, INC. [read post]
19 Oct 2017, 10:29 am
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
19 Oct 2017, 10:29 am
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
19 Oct 2017, 7:36 am
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED October 16, 2017, Order) (Bryson, CJ) [read post]
16 Oct 2017, 12:36 pm
Teva Pharmaceuticals USA Inc. [read post]
24 Sep 2017, 5:04 pm
Teva Pharmaceuticals USA, Inc. [read post]
23 Sep 2017, 12:39 pm
USA, Inc. v. [read post]
29 Aug 2017, 7:35 am
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED August 25, 2017, Order) (Bryson, CJ) [read post]
17 Aug 2017, 7:49 am
USA, Inc. v. [read post]
20 Jul 2017, 12:47 pm
On July 7, 2017, Teva Pharmaceuticals USA, Inc. filed a complaint in the Eastern District of Pennsylvania alleging that a former executive disclosed confidential information to a romantic partner who happens to be an executive of one of Teva’s direct competitors. [read post]